Chronic Kidney Disease-Associated Defect in Humoral Immune Response Is Driven by Inflammation.

Area of Science:

• Immunology
• Nephrology
• Translational Medicine

Background:

• Advanced chronic kidney disease (CKD) is linked to poor humoral immunity, leading to higher infection mortality and reduced vaccine effectiveness.
• Uremic toxins accumulate in CKD, but their direct impact on T and B cell function is not fully understood.
• Defective immune responses in CKD patients pose significant health challenges, particularly concerning infectious diseases and vaccination.

Purpose of the Study:

• To investigate the mechanisms behind impaired humoral immunity in patients with advanced CKD.
• To determine whether uremic toxins directly affect T-B cell cooperation and antibody production.
• To identify the primary drivers of immune dysfunction in CKD.

Main Methods:

• Integrated clinical and biological data from 106 CKD patients.
• Utilized in vitro and in vivo murine models for mechanistic studies.
• Assessed T-B cell cooperation via coculture assays and measured vaccine-induced antibody titers.

Main Results:

• Contrary to hypothesis, indoxyl sulfate did not directly impair T-B cell cooperation.
• Plasma levels of major uremic toxins did not correlate with vaccine-induced antibody titers.
• Systemic inflammation was identified as the primary cause of defective humoral immunity in CKD.

Conclusions:

• CKD-associated inflammation, not uremic toxins, underlies humoral immune dysfunction.
• Inflammation disrupts lymphoid architecture and impairs antibody production in murine models.
• Targeting inflammation may enhance vaccine efficacy and reduce infection risks in CKD patients.